DECISION+, a Training Program to Improve Optimal Drug Prescription

Acute Respiratory Infections Clinical Trial

— Decision+  

Official title:

DECISION+: Une Formation Pour Les médecins de Famille Sur la Prise de décision partagée Afin d'Optimiser Les décisions Cliniques Concernant l'Utilisation d'Antibiotiques Pour Les Infections aiguës Des Voies Respiratoires (IAVR)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01116076
• Other study ID #: FRSQ20131
• Secondary ID: 35247
• Status: Completed
• Phase: Phase 1
• First received: May 3, 2010
• Last updated: January 30, 2013
• Start date: May 2010
• Est. completion date: April 2011

Study information

• Verified date: January 2013
• Source: Centre Hospitalier Universitaire de Québec, CHU de Québec
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Fonds de la recherche en santé du Québec
• Study type: Interventional

Clinical Trial Summary

Decisions about the use of antibiotics for acute respiratory infections are the most frequently reported reason for consulting a family physician. Although it varies according to the specific type of acute respiratory infections, the use of antibiotics is estimated to be 63% to 67%, well above the expected prevalence of bacterial infections thus suggesting overuse of antibiotics. Consequently, there is an urgent need for helping family physicians and their patients to improve the clinical decision making process regarding the use of antibiotics for acute respiratory infections. We will evaluate the impact of DECISION +, a multifaceted intervention program that includes training in shared decision making, reminders and feedback targeting physicians, and decision support tools targeting patients on the decision to use antibiotics for acute respiratory infections. Results from this study will lay the ground for a national strategy targeting the improvement of the clinical decision making process regarding antibiotic use for acute respiratory infections in primary care. In turn, this will increase quality of care and patient safety.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 712
• Est. completion date: April 2011
• Est. primary completion date: April 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

FAMILY PHYSICIANS:

Inclusion Criteria:

• All FP (teachers and residents) providing care in the walk-in clinic in each Family Practice Teaching Unit (FPTU) will be eligible to participate in the trial.

Exclusion Criteria:

• he/she was involved or participated in the DECISION + pilot RCT

• he/she is not expected to be practicing at the FPTU for the whole duration of the study (e.g. residents ending their residency program or doing rotations outside of the FPTU, planned pregnancy/delivery, planned retirement).

PATIENTS:

Inclusion Criteria:

• if 17 years old and under, must be accompanied by a parents or a guardians)

• they are consulting a participating physician for an ARI, for which treatment with an antibiotic is considered

• they are able (patients or the accompanying parent or guardians) to read, understand and write French (expected level: 8th grade)

• they give informed consent

Exclusion Criteria:

• Patients with a condition requiring emergency care will be excluded.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Acute Respiratory Infections
• Respiratory Tract Infections

Intervention

Behavioral:
• Decision+ program (to improve optimal drug prescription for ARI)
DECISION+ is a multifaceted intervention program that includes: On site course and Internet-based courses (2x120 min), reminders of expected behaviours and feedback.

Locations

Country	Name	City	State
Canada	Centre Hospitalier Université Laval - Hôpital St-François d'Assise	Quebec

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Québec, CHU de Québec

Country where clinical trial is conducted

Canada, 

References & Publications (2)

Légaré F, Labrecque M, Cauchon M, Castel J, Turcotte S, Grimshaw J. Training family physicians in shared decision-making to reduce the overuse of antibiotics in acute respiratory infections: a cluster randomized trial. CMAJ. 2012 Sep 18;184(13):E726-34. d — View Citation

Légaré F, Labrecque M, Godin G, LeBlanc A, Laurier C, Grimshaw J, Castel J, Tremblay I, Frémont P, Cauchon M, Lemieux K, Rhéaume C. Training family physicians and residents in family medicine in shared decision making to improve clinical decisions regarding the use of antibiotics for acute respiratory infections: protocol for a clustered randomized controlled trial. BMC Fam Pract. 2011 Jan 26;12:3. doi: 10.1186/1471-2296-12-3. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of patients reporting a decision for "immediate antibiotics."		After index consultation	No
Secondary	Decision to use antibiotics	After an index consultation, we will ask patients: "Was a prescription for an antibiotic or a sample of antibiotic provided to treat an ARI (acute otitis media, acute bronchitis, acute pharyngitis, or acute rhinosinusitis)?" Possible answers will be: Yes,(Immediate antibiotics); Yes,(Delayed antibiotics); No (no antibiotics).	After index consultation	No
Secondary	Decisional conflict	Will be assessed with the Decisional Conflict Scale (DCS) after the index consultation. This questionnaire is similar for physicians and patients and includes 19 items, on a five-point Likert scale, divided into five subscales that are i)uncertainty and its modifiable deficits: ii) knowledge, iii) values clarification, iv) support and v) perception of an effective choice. Both the physician and patient versions of the DCS have adequate psychometric properties and have the same meaning for both physicians and patients.	After index consultation	No
Secondary	Adherence to the decision that was made	2 weeks after the index consultation, patients will be asked via a telephone interview: "What was the decision made with the FP about antibiotic use for ARI two weeks ago?" and "Have you complied with this decision?" (yes or no). If patients answer "no", research assistants, using an open-ended question, will inquire about the reasons and the options that were adhered to. Interviewers will be unaware of the study group and will be instructed not to ask questions that could reveal the study group.	2 weeks after the index consultation	No
Secondary	Decisional regret	2 weeks after the index consultation, decisional regret will be assessed in patients using the Decisional Regret Scale (DRS) via a telephone interview. The DRS is a 5-item scale with adequate psychometric properties that correlates strongly with decision satisfaction and overall QOL.	2 weeks after the index consultation	No
Secondary	Quality of life (QOL)	For patients only, before and two weeks after the index consultation (via a telephone interview), QOL will be assessed using the Short Form-12 (SF-12V2 Health survey). This questionnaire measures general health status from the patient's point of view and includes eight concepts commonly represented in health status: physical functioning, role functioning, bodily pain, general health, vitality, social functioning, and emotional and mental health.	Baseline and 2 weeks after the index consultation	No
Secondary	Intention to engage in SDM in future consultations dealing with antibiotic use for ARI	In FP and their patients, this intention will be assessed based on the Theory of planned behavior (TPB). The questionnaire includes 15 items, on a 7-point Likert scale, that cover the constructs of the TPB, namely attitudes, social norm, perceived behavioral control and intention. Patients will complete this questionnaire before and 2 weeks after the index consultation; physicians will complete it once during the baseline data collection period and after the last encounter of the post-intervention data collection period.	Baseline and 2 weeks after the index consultation	No

External Links

•   Link